Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Evaluating the performance of four anti-dsDNA antibody detection methods

Abstract

Objective To evaluate the concordance of four anti-dsDNA antibody detection methods—Crithidia luciliae indirect immunofluorescence test (CLIFT), enzyme-linked immunosorbent assay (ELISA), acridine ester direct chemiluminescence immunoassay (CLIA), and digital liquid chip method (DLCM)—and to assess their diagnostic efficacy in systemic lupus erythematosus (SLE) patients. Methods A total of 285 serum samples were collected, including 170 SLE patients, 39 with non-SLE autoimmune diseases (AIDs), 28 with non-AIDs, and 48 undiagnosed cases. The concordance and diagnostic performance of anti-dsDNA antibody methods were analyzed. Results The diagnostic performance showed that DLCM exhibited the highest sensitivity (86.87%), while CLIA demonstrated the highest specificity (94.03%). The area under the receiver operating characteristic (ROC) curve (AUC) was ranked as CLIFT < ELISA < CLIA < DLCM (AUC = 0.938). Anti-dsDNA antibodies detected by both CLIFT and DLCM correlated well with the SLE disease activity index (SLEDAI), while CLIFT and CLIA were significantly correlated with lupus nephritis. Utilizing ROC curve-derived cut-off values, the overall concordance of CLIFT and other methods ranged from 80.14% to 82.58% (kappa > 0.6, P < 0.001), and the concordance between quantitative methods ranged from 89.55% to 91.29% (kappa > 0.8, P < 0.001). Conclusion CLIFT, ELISA, CLIA, and DLCM all showed impressive diagnostic efficacy in detecting anti-dsDNA antibodies. CLIFT shows a strong correlation with SLE activity and lupus nephritis. DLCM, a relatively new method, also showed excellent performance and could be integrated into clinical laboratory workflows for anti-dsDNA antibody testing.

Overview

Integrity signals

Registry

Crossref · 10.1177/09612033251371116

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 33 references

Research works printed but not linked: 1

  1. Group CLNDaTGW. Chinese guidelines for diagnosis and treatment of lupus nephritis. Zhonghua Yixue Zazhi 2019; 99: 3441–3455.

Metadata

Authors
Gao, X., Wu, L., Li, Y., Wang, L., Huang, Z., Zhang, J., Su, Z., & Yang, B.
Affiliations
  • Sichuan University (CN)
  • Clinical Laboratory, Baoshan People’s Hospital of Yunnan Province, Baoshan, China
Corresponding author
  • Su, Zhenzhen
  • Yang, Bin
Venue
Lupus
Published
2025-08-23
Volume
34
Issue
12
Pages
1251-1260
ISSN
  • 0961-2033 (ISSN-L)
  • 1477-0962
OpenAlex
W4413452534
Cited by
1
References
33
Citations by year
2026: 1
FWCI
0.72
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Lupus (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Natural Science Foundation of Sichuan Province (2024YFFK0222)
  • National Key R&D Program of China (2022YFC2406600/2022YFC2406604)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
Keywords
anti-dsDNA antibodies, systemic lupus erythematosus, chemiluminescence immunoassay, ELISA, diagnostic agreement, sensitivity and specificity, SLE disease activity, lupus nephritis, autoimmune disease diagnosis
MeSH terms
Adult, Animals, Antibodies, Antinuclear, Crithidia, DNA, Enzyme-Linked Immunosorbent Assay, Female, Humans, Luminescent Measurements, Lupus Erythematosus, Systemic, Lupus Nephritis, Male, Middle Aged, ROC Curve, Sensitivity and Specificity, Fluorescent Antibody Technique, Indirect, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluating the performance of four anti-dsDNA antibody detection methods. https://app.cochat.ai/papers/10.1177/09612033251371116
The paper
Gao, X., Wu, L., Li, Y., Wang, L., Huang, Z., Zhang, J., Su, Z., & Yang, B. (2025). Evaluating the performance of four anti-dsDNA antibody detection methods. Lupus. https://doi.org/10.1177/09612033251371116

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.